DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Taylor PC, Keystone EC, van der Heijde D. et al.
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
N Engl J Med 2017;
376: 652-662
We do not assume any responsibility for the contents of the web pages of other providers.